期刊文献+

阿尔茨海默病微血管改变及其机制 被引量:4

Microvascular changes and the mechanism in Alzheimer's disease
下载PDF
导出
摘要 阿尔茨海默病发病机制至今尚未完全明确,但局部微血管改变发生于神经退行性变和认知功能障碍之前,且局部脑血流量降低先于临床症状的现象已经大量研究证实,提示脑微血管改变可能是阿尔茨海默病进展过程中的催化剂,参与其发生与发展。本文通过对阿尔茨海默病脑微血管结构,以及血管内皮生长因子、氧化应激反应、β-淀粉样蛋白对微血管影响相关研究进展的概述,以探讨阿尔茨海默病的可能发病机制。 Till now, the pathogenic mechanism of Alzheimer's disease(AD) is not completely clear.Extensive literatures have shown that the local cerebral microvascular disease occurs before neurodegeneration and cognitive impairment, and local blood flow reduction happens before the clinical symptoms of AD. This reveals that the microvascular changes are probably the important pathogenic manifestation in the AD formation and involved in the occurrence and development of AD. In this review,we explore the possible pathogenic mechanism of AD by analyzing the morphological changes of microvasculature, and the effects of vascular endothelial growth factor(VEGF), oxidative stress and amyloid β-protein(Aβ) on microvasculature respectively.
出处 《中国现代神经疾病杂志》 CAS 2016年第5期303-306,共4页 Chinese Journal of Contemporary Neurology and Neurosurgery
基金 国家自然科学基金青年科学基金资助项目(项目编号:81200834) 辽宁省自然科学基金资助项目(项目编号:2013021070) 辽宁省沈阳市科技计划项目(项目编号:F10-205-1-10)~~
关键词 阿尔茨海默病 血管内皮生长因子类 氧化性应激 淀粉样蛋白 综述 Alzheimer disease Vascular endothelial growth factors Oxidative stress Amyloid Review
  • 相关文献

参考文献42

  • 10stergaard L, Aamand R, Guti6rrez-Jimenez E, Ho YC, BlicherJU, Madsen SM, Nagenthiraja K, Dalby RB, Drasbek KR,M0ller A, Braendgaard H, Mouridsen K, Jespersen SN, JensenMS, West MJ. The capillary dysfunction hypothesis ofAlzheimer's disease. Neurobiol Aging, 2013, 34:1018-1031.
  • 2Bourasset F, Ouellet M, Tremblay C, Julien C, Do TM, Oddo S,LaFerla F, Calon F. Reduction of the cerebrovascular volume ina transgenic mouse model of Alzheimer's disease.Neuropharmacology, 2009, 56:808-813.
  • 3步青云,高堂珂,李芙,高杨,薛卫国.阿尔茨海默病脑内β-淀粉样蛋白经血-脑屏障清除相关研究概况[J].中国脑血管病杂志,2014,11(12):663-668. 被引量:7
  • 4Farkas E, Luiten PG. Cerebral microvascular pathology in agingand Alzheimer's disease. Prog Neurobiol, 2001,64:575-611.
  • 5Mann DM, Eaves NH, Marcyniuk B, Yates PO. Quantitativechanges in cerebral cortical microvasculature in ageing anddementia. Neurobiol Aging, 1986, 7:321-330.
  • 6Bu6e L, Hof PR, Bouras C, Delacourte A, Perl DP, MorrisonJH, Fillit HM. Pathological alterations of the cerebralmicrovasculature in Alzheimer、disease and related dementingdisorders. Acta Neuropathol, 1994, 87:469-480.
  • 7Bell MA, Ball MJ. Morphometric comparison of hippocampalmicrovasculature in ageing and demented people: diameters anddensities. Acta Neuropathol, 1981, 53:299-318.
  • 8Hassler 0. Vascular changes in senile brains: a microangiographic study. Acta Neuropathol, 1965, 5:40-53.
  • 9Ravens JR. Vascular changes in the human senile brain. Adv Neurol, 1978, 20:487-501.
  • 10Bu6e L, Hof PR, Delacourte A. Brain microvascular changes inAlzheimer's disease and other dementias. Ann NY Acad Sci,1997,826:7-24.

二级参考文献52

  • 1Banks WA, Robinson SM, Verma S, et al. Efflux of human and mouse amyloid beta proteins 1-40 and 1-42 from brain: impairment in a mouse model of Alzheimer' s disease [ J ]. Neuroseienee ,2003,121 (2) :487-492.
  • 2Rosenberg RN. The molecular and genetic basis of AD : the end of the beginning: the 2000 Wartenberg lecture [ J ]. Neurology, 2000,54 ( 11 ) : 2045-2054.
  • 3Sambamurti K, Greig NH, Lahiri DK. Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer' s disease [ J ] . Neuromolecular Med,2002,1(1) :1-31.
  • 4Tanzi RE,Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis : a genetic perspective [ J]. Cell ,2005,20 (4) :545-555.
  • 5Kook SY, Hong HS, Moon M, et al. Aβ1-42-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca2+-calcineurn signaling [ J ]. J Neurosci, 2012, 32 (26) :8845- 8854.
  • 6Glenner GG,Wong CW. Alzheimer's disease and Down's syndrome:sharing of a unique cerebrovascular amyloid fibril protein[ J]. Biochem Biophys Ree Common, 1984, 122(3) :1131-1135.
  • 7Masters CL, Simms G, Weinman NA, et, al. Amyloid plaque core protein in Alzheimer disease and Down syndrome[ J ]. Proc Natl Acad Sci U S A, 1985,82 (12) : 4245 -4249.
  • 8Hardy JA, Higgins GA. Alzheimer's disease:the amyloid cascade hypothesis [ J ]. Science, 1992, 256 ( 5054 ) : 184-185.
  • 9Poirier J, Delisle MC, Quirion R, et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease [ J ]. Proc Natl Acad Sci U S A,1995,92(26) :12260-12264.
  • 10Bellucci A, Luccarini I, Scali C, et al. Cholinergic dysfunction,neuronal damage and axonal loss in TgCRND8 mice [ J ]. Neurobiol Dis, 2006,23 (2) : 260-272.

共引文献6

同被引文献26

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部